Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-09-19 | Immunome Inc. | Rosett Max
(Chief Financial Officer) |
S | Common Stock | D | 14380 | $16.01 - $16.01 | $230,223 |
| 2024-09-19 | Immunome Inc. | Rosett Max
(Chief Financial Officer) |
M | Common Stock | A | 42000 | $1.05 - $1.05 | $44,100 |
| 2024-08-16 | Immunome Inc. | BIENAIME JEAN JAC...
(Director) |
P | Common Stock | A | 7000 | $13.94 - $13.94 | $97,608 |
| 2024-08-15 | Immunome Inc. | Higgins Jack
(Chief Scientific Officer) |
S | Common Stock | D | 3524 | $13.93 - $13.93 | $49,071 |
| 2024-08-15 | Immunome Inc. | Higgins Jack
(Chief Scientific Officer) |
M | Common Stock | A | 19524 | $1.35 - $1.35 | $26,357 |
| 2024-08-19 | Immunome Inc. | Higgins Jack
(Chief Scientific Officer) |
G | Common Stock | D | 2471 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |